UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | X | Z
Number of items: 513.

A

Abeti, R; Duchen, MR; (2012) Activation of PARP by Oxidative Stress Induced by beta-Amyloid: Implications for Alzheimer's Disease. NEUROCHEMICAL RESEARCH , 37 (11) pp. 2589-2596. 10.1007/s11064-012-0895-x.

Abeti, R; Duchen, MR; (2012) Activation of PARP by Oxidative Stress Induced by β-Amyloid: Implications for Alzheimer's Disease. Neurochemical Research pp. 1-8.

Acharya, S; Nagy, A; Budu, C; Treacy, C; Fearnley, J; Lees, AJ; Giovannoni, G; (2012) The new bradykinesia akinesia incoordination (BRAIN) test: People with Parkinson's disease versus healthy controls. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S102-S102). WILEY-BLACKWELL

Aenkoe, M-L; Mueller-McNicoll, M; Brandl, H; Curk, T; Gorup, C; Henry, I; Ule, J; (2012) The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes. GENOME BIOLOGY , 13 (3) 10.1186/gb-2012-13-3-r17.

Ahmed, M; Miller, A; Hanna, MG; Greensmith, L; (2012) Investigating the effects of pharmacological up-regulation of the heat shock response in an in-vitro model of sporadic inclusion body myositis. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S26-S26). PERGAMON-ELSEVIER SCIENCE LTD

Ahmed, Z; Asi, YT; Sailer, A; Lees, AJ; Houlden, H; Revesz, T; Holton, JL; (2012) The neuropathology, pathophysiology and genetics of multiple system atrophy. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 38 (1) pp. 4-24. 10.1111/j.1365-2990.2011.01234.x.

Ahmed, Z; Revesz, T; Holton, JL; (2012) Neuropathology and pathophysiology of multiple system atrophy Response. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 38 (4) p. 381. 10.1111/j.1365-2990.2012.01266.x.

Ahmed, Z; Revesz, T; Holton, JL; (2012) Neuropathology and pathophysiology of multiple system atrophy Response. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 38 (4) p. 381. 10.1111/j.1365-2990.2012.01266.x.

Alg, VS; Sofat, R; Houlden, H; Grieve, J; Watkins, LD; Werring, DJ; (2012) Genetic association studies of intracranial aneurysms: systematic review and meta-analysis in over 106 000 individuals. INTERNATIONAL JOURNAL OF STROKE , 7 p. 8.

Alquezar, C; Esteras, N; Alzualde, A; Moreno, F; Ayuso, MS; López de Munain, A; Martín-Requero, Á; (2012) Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A. PLoS One , 7 (5) , Article e37057. 10.1371/journal.pone.0037057.

Alquezar, C; Esteras, N; Bartolomé, F; Merino, JJ; Alzualde, A; López de Munain, A; Martín-Requero, Á; (2012) Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia. Neurobiol Aging , 33 (2) 429.e7-429.20. 10.1016/j.neurobiolaging.2010.11.020.

Andreasson, U; Portelius, E; Pannee, J; Zetterberg, H; Blennow, K; (2012) Multiplexing and multivariate analysis in neurodegeneration. METHODS , 56 (4) pp. 464-470. 10.1016/j.ymeth.2012.02.004.

Andreasson, U; Vanmechelen, E; Shaw, LM; Zetterberg, H; Vanderstichele, H; (2012) Analytical aspects of molecular Alzheimer's disease biomarkers. BIOMARKERS IN MEDICINE , 6 (4) pp. 377-389. 10.2217/BMM.12.44.

Angel, TE; Jacobs, JM; Spudich, SS; Gritsenko, MA; Fuchs, D; Liegler, T; Zetterberg, H; ... Smith, RD; + view all (2012) The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin Proteomics , 9 (1) 3-. 10.1186/1559-0275-9-3.

Antsov, E; Kilk, S; Silveira-Moriyama, L; Kadastik-Eerme, L; Toomsoo, T; Paju, T; Lees, A; (2012) Adapting the Sniffin' Sticks olfactory test to diagnose Parkinson's disease in Estonia. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S500-S500). WILEY-BLACKWELL

Apaydin, H; Benbir, G; Lees, A; (2012) A stimulus-sensitive tic disorder characterized by echophenomena and coprolalia. Mov Disord , 27 (1) pp. 159-160. 10.1002/mds.23952.

Aviles-Olmos, I; Kefalopoulou, Z; Djamshidian, A; Limousin, P; Dickson, J; Lees, A; Foltynie, T; (2012) An open label, single site, 12 month, phase II, randomised controlled trial evaluating the safety and efficacy of Exendin-4 (Exenatide) in the treatment of patients with moderate severity Parkinson's disease. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S109-S109). WILEY-BLACKWELL

B

Bartlett, JW; Frost, C; Mattsson, N; Skillbaeck, T; Blennow, K; Zetterberg, H; Schott, JM; (2012) Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. BIOMARKERS IN MEDICINE , 6 (4) pp. 391-400. 10.2217/BMM.12.49.

Baruch, N; Duchen, M; Hanna, MG; (2012) Muscle degeneration in ion channel dysfunction. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S16-S16). PERGAMON-ELSEVIER SCIENCE LTD

Beall, C; Hamilton, DL; Gallagher, J; Logie, L; Wright, K; Soutar, MP; Dadak, S; ... Ashford, MLJ; + view all (2012) Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour. DIABETOLOGIA , 55 (9) pp. 2432-2444. 10.1007/s00125-012-2617-y.

Bech, S; Hjermind, LE; Salvesen, L; Nielsen, JE; Heegaard, NHH; Jorgensen, HL; Rosengren, L; ... Winge, K; + view all (2012) Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes. PARKINSONISM & RELATED DISORDERS , 18 (1) pp. 69-72. 10.1016/j.parkreldis.2011.08.012.

Bellenguez, C; Bevan, S; Gschwendtner, A; Spencer, CCA; Burgess, AI; Pirinen, M; Jackson, CA; ... Markus, HS; + view all (2012) Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. NATURE GENETICS , 44 (3) 328-U141. 10.1038/ng.1081.

BenMoyal-Segal, L; Soreq, L; Ben-Shaul, Y; Ben-Ari, S; Ben-Moshe, T; Aviel, S; Bergman, H; (2012) Adaptive Alternative Splicing Correlates with Less Environmental Risk of Parkinsonism. NEURODEGENERATIVE DISEASES , 9 (2) pp. 87-98. 10.1159/000331328.

Bendlin, BB; Carlsson, CM; Johnson, SC; Zetterberg, H; Blennow, K; Willette, AA; Okonkwo, OC; ... Sager, MA; + view all (2012) CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. PLoS One , 7 (6) , Article e37720. 10.1371/journal.pone.0037720. Green open access
file

Benilova, I; Karran, E; De Strooper, B; (2012) The toxic A beta oligomer and Alzheimer's disease: an emperor in need of clothes. NATURE NEUROSCIENCE , 15 (3) pp. 349-357. 10.1038/nn.3028.

Bezprozvanny, I; Supnet, C; Sun, S; Zhang, H; De Strooper, B; (2012) Response to Shilling et al. JOURNAL OF BIOLOGICAL CHEMISTRY , 287 (24) p. 20469. 10.1074/jbc.L112.356790.

Bis, JC; DeCarli, C; Smith, AV; van der Lijn, F; Crivello, F; Fornage, M; Debette, S; ... Seshadri, S; + view all (2012) Common variants at 12q14 and 12q24 are associated with hippocampal volume. NATURE GENETICS , 44 (5) 545-+. 10.1038/ng.2237.

Blazquez, L; Jovanna Gonzalez-Rojas, S; Abad, A; Razquin, N; Abad, X; Fortes, P; (2012) Increased in vivo inhibition of gene expression by combining RNA interference and U1 inhibition. NUCLEIC ACIDS RESEARCH , 40 (1) 10.1093/nar/gkr956.

Blennow, K; Hardy, J; Zetterberg, H; (2012) The Neuropathology and Neurobiology of Traumatic Brain Injury. NEURON , 76 (5) pp. 886-899. 10.1016/j.neuron.2012.11.021.

Blennow, K; Zetterberg, H; Fagan, AM; (2012) Fluid Biomarkers in Alzheimer Disease. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE , 2 (9) 10.1101/cshperspect.a006221.

Blennow, K; Zetterberg, H; Rinne, JO; Salloway, S; Wei, J; Black, R; Grundman, M; (2012) Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease. ARCHIVES OF NEUROLOGY , 69 (8) pp. 1002-1010. 10.1001/archneurol.2012.90.

Borgegard, T; Gustavsson, S; Nilsson, C; Parpal, S; Klintenberg, R; Berg, A-L; Rosqvist, S; ... Lundkvist, J; + view all (2012) Alzheimer's Disease: Presenilin 2-Sparing gamma-Secretase Inhibition Is a Tolerable A beta Peptide-Lowering Strategy. JOURNAL OF NEUROSCIENCE , 32 (48) pp. 17297-17305. 10.1523/JNEUROSCI.1451-12.2012.

Brady, S; Squier, W; Hilton-Jones, D; Sewry, C; Hanna, M; Holton, JL; (2012) A histological evaluation of protein accumulation in inflammatory myopathies. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S27-S27). PERGAMON-ELSEVIER SCIENCE LTD

Brady, S; Squier, W; Hilton-Jones, D; Sewry, C; Holton, JL; (2012) INCLUSION BODY MYOSITIS: A DIAGNOSTIC CHALLENGE. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Bras, J; Guerreiro, R; Hardy, J; (2012) Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. NATURE REVIEWS NEUROSCIENCE , 13 (7) pp. 453-464. 10.1038/nrn3271.

Bras, J; Verloes, A; Schneider, SA; Mole, SE; Guerreiro, RJ; (2012) Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Human Molecular Genetics , 21 (12) 2646 - 2650. 10.1093/hmg/dds089. Green open access
filefile

Brinkmalm, G; Portelius, E; Ohrfelt, A; Mattsson, N; Persson, R; Gustavsson, MK; Vite, CH; ... Brinkmalm, A; + view all (2012) An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid beta and amyloid precursor protein in human and cat cerebrospinal fluid. JOURNAL OF MASS SPECTROMETRY , 47 (5) pp. 591-603. 10.1002/jms.2987.

Bromander, S; Anckarsater, R; Kristiansson, M; Blennow, K; Zetterberg, H; Anckarsater, H; Wass, CE; (2012) Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. JOURNAL OF NEUROINFLAMMATION , 9 (ARTN 242) 10.1186/1742-2094-9-242.

Brouillette, J; Caillierez, R; Zommer, N; Alves-Pires, C; Benilova, I; Blum, D; De Strooper, B; (2012) Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid-beta(1-42) Oligomers Are Revealed In Vivo by Using a Novel Animal Model. JOURNAL OF NEUROSCIENCE , 32 (23) pp. 7852-7861. 10.1523/JNEUROSCI.5901-11.2012.

Bruno, D; Pomara, N; Nierenberg, J; Ritchie, JC; Lutz, MW; Zetterberg, H; Blennow, K; (2012) Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants. EXPERIMENTAL GERONTOLOGY , 47 (5) pp. 347-352. 10.1016/j.exger.2011.09.008.

Buchhave, P; Minthon, L; Zetterberg, H; Wallin, AK; Blennow, K; Hansson, O; (2012) Cerebrospinal Fluid Levels of beta-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia. ARCHIVES OF GENERAL PSYCHIATRY , 69 (1) pp. 98-106.

Burge, J; Schorge, S; Hanna, MG; (2012) Progesterone reduces and shifts the voltage dependence of the skeletal muscle chloride conductance. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S16-S16). PERGAMON-ELSEVIER SCIENCE LTD

Burge, JA; Hanna, MG; (2012) Novel Insights into the Pathomechanisms of Skeletal Muscle Channelopathies. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS , 12 (1) pp. 62-69. 10.1007/s11910-011-0238-3.

Burke, A; Mantuano, E; Bhatia, KP; Veneziano, L; Giunti, P; (2012) NOVEL DE NOVO MUTATION CAUSING BENIGN HEREDITARY CHOREA WITH HYPOTHRYOIDISM AND A PITUITARY MASS. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. (pp. A11-A11). BMJ PUBLISHING GROUP

Burns, S; Zenner, H; Plagnol, V; Curtis, J; Mok, K; Eisenhut, M; Kumararatne, D; ... Nejentsev, S; + view all (2012) EXOME SEQUENCINGIDENTIFIES LRBA GENE DELETION IN A PATIENT PRESENTING WITH AUTOIMMUNITY WITHOUT HYPOGAMMAGLOBULINEMIA. In: (Proceedings) 15th Biennial Meeting European-Society-for-Immunodeficiency (ESID). (pp. p. 398). SPRINGER/PLENUM PUBLISHERS

Burns, SO; Zenner, HL; Plagnol, V; Curtis, J; Mok, K; Eisenhut, M; Kumararatne, D; ... Nejentsev, S; + view all (2012) LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , 130 (6) pp. 1428-1432. 10.1016/j.jaci.2012.07.035.

Burns, SO; Zenner, HL; Plagnol, V; Curtis, J; Mok, K; Eisenhut, M; Kumararatne, D; ... Nejentsev, S; + view all (2012) LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. Journal of Allergy and Clinical Immunology , 130 (6) pp. 1428-1432. 10.1016/j.jaci.2012.07.035.

C

Cai, J; Qi, X; Kociok, N; Skosyrski, S; Emilio, A; Ruan, Q; Han, S; ... Boulton, ME; + view all (2012) ss-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment. EMBO MOLECULAR MEDICINE , 4 (9) pp. 980-991. 10.1002/emmm.201101084.

Camargos, S; Lees, AJ; Singleton, A; Cardoso, F; (2012) DYT16: The original cases. Journal of Neurology, Neurosurgery and Psychiatry , 83 (10) pp. 1012-1014. 10.1136/jnnp-2012-302841.

Camargos, S; Lees, AJ; Singleton, A; Cardoso, F; (2012) DYT16: the original cases. J Neurol Neurosurg Psychiatry , 83 (10) pp. 1012-1014. 10.1136/jnnp-2012-302841.

Cambray, S; Arber, C; Little, G; Dougalis, AG; de Paola, V; Ungless, MA; Li, M; (2012) Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors. NATURE COMMUNICATIONS , 3 (ARTN 841) 10.1038/ncomms1817.

Cardoso, F; Vale, T; Lees, A; (2012) Gowers' Queen Square Case Notes on Chorea. In:

Carmeliet, P; De Strooper, B; (2012) ALZHEIMER'S DISEASE A breach in the blood-brain barrier. NATURE , 485 (7399) pp. 451-452.

Casas, JP; Hingorani, AD; (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet , 379 (9822) 1214 - 1224. 10.1016/S0140-6736(12)60110-X. Green open access
file

Charlesworth, G; Gandhi, S; Bras, JM; Barker, RA; Burn, DJ; Chinnery, PF; Gentleman, SM; ... Wood, NW; + view all (2012) Tau acts as an independent genetic risk factor in pathologically proven PD. NEUROBIOLOGY OF AGING , 33 (4) 10.1016/j.neurobiolaging.2011.11.001.

Charlesworth, G; Gandhi, S; Bras, JM; Barker, RA; Burn, DJ; Chinnery, PF; Gentleman, SM; ... Wood, NW; + view all (2012) Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiology of Aging , 33 (4) 10.1016/j.neurobiolaging.2011.11.001.

Charlesworth, G; Gandhi, S; Bras, JM; Gentleman, SM; Guerreiro, R; Hardy, J; Holton, JL; ... Wood, NW; + view all (2012) First stage association analysis of neuropatholically proven PD confirms MAPT as an independent risk factor for PD. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S450-S451). WILEY-BLACKWELL

Charlesworth, G; Plagnol, V; Holmström, KM; Bras, J; Sheerin, UM; Preza, E; Rubio-Agusti, I; ... Wood, NW; + view all (2012) Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. The American Journal of Human Genetics , 91 (6) 1041 - 1050. 10.1016/j.ajhg.2012.10.024. Green open access
file

Charlesworth, G; Wood, NW; (2012) Mutations in nuclear genes that affect mitochondrial function in parkinson’s disease. In: Mitochondrial Dysfunction in Neurodegenerative Disorders. (pp. 43-61).

Chavez-Gutierrez, L; Bammens, L; Benilova, I; Vandersteen, A; Benurwar, M; Borgers, M; Lismont, S; ... De Strooper, B; + view all (2012) The mechanism of gamma-Secretase dysfunction in familial Alzheimer disease. EMBO JOURNAL , 31 (10) pp. 2261-2274. 10.1038/emboj.2012.79.

Chung, HY; Machado, P; van der Heijde, D; D'Agostino, M-A; Dougados, M; (2012) Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. ANNALS OF THE RHEUMATIC DISEASES , 71 (6) pp. 809-816. 10.1136/annrheumdis-2011-200180.

Clark, CN; Weber, YW; Lerche, H; Warner, TT; (2012) Paroxysmal exercise-induced dyskinesia of the hands. MOVEMENT DISORDERS , 27 (12) pp. 1579-1580. 10.1002/mds.25200.

Clark, R; Maennikkoe, R; Stuckey, DJ; Iberl, M; Clarke, K; Ashcroft, FM; (2012) Mice expressing a human K-ATP channel mutation have altered channel ATP sensitivity but no cardiac abnormalities. DIABETOLOGIA , 55 (4) pp. 1195-1204. 10.1007/s00125-011-2428-6.

Connick, P; Kolappan, M; Crawley, C; Webber, DJ; Patani, R; Michell, AW; Du, M-Q; ... Chandran, S; + view all (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. LANCET NEUROLOGY , 11 (2) pp. 150-156. 10.1016/S1474-4422(11)70305-2.

Cooper-Knock, J; Hewitt, C; Highley, JR; Brockington, A; Milano, A; Man, S; Martindale, J; ... Shaw, PJ; + view all (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain , 135 (3) 751 - 764. 10.1093/brain/awr365. Green open access
file

Coppola, G; Chinnathambi, S; Lee, JJ; Dombroski, BA; Baker, MC; Soto-Ortolaza, AI; Lee, SE; ... Geschwind, DH; + view all (2012) Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimers diseases. HUMAN MOLECULAR GENETICS , 21 (15) pp. 3500-3512. 10.1093/hmg/dds161.

Corradi, L; Porro, I; Schenone, A; Momeni, P; Ferrari, R; Nobili, F; Ferrara, M; ... Fato, MM; + view all (2012) A repository based on a dynamically extensible data model supporting multidisciplinary research in neuroscience. BMC Medical Informatics and Decision Making , 12 (1) 10.1186/1472-6947-12-115. Gold open access

Corrêa, SAL; Hunter, CJ; Palygin, O; Wauters, SC; Martin, KJ; McKenzie, C; McKelvey, K; ... Frenguelli, BG; + view all (2012) MSK1 regulates homeostatic and experience-dependent synaptic plasticity. J Neurosci , 32 (38) pp. 13039-13051. 10.1523/JNEUROSCI.0930-12.2012.

Cortese, A; Machado, P; Miller, A; Brady, S; Hilton-Jones, D; Morrow, J; Hiscock, A; ... Hanna, M; + view all (2012) CLINICAL FEATURES AND CLINICAL COURSE OF SPORADIC INCLUSION BODY MYOSITIS (IBM): A PROSPECTIVE COHORT STUDY: IBM-NET. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Cortese, A; Machado, P; Morrow, J; Dewar, L; Hiscock, A; Miller, A; Brady, S; ... Hanna, MG; + view all (2012) The natural history of sporadic inclusion body myositis: data from the IBM-Net prospective cohort study. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S27-S27). PERGAMON-ELSEVIER SCIENCE LTD

Cottenie, E; Laura, M; Hanna, M; Dick, D; Blake, J; Houlden, H; Reilly, MM; (2012) Genetic analysis of FIG4 in patients with CMT. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S18-S18). PERGAMON-ELSEVIER SCIENCE LTD

Crehan, H; Hardy, J; Pocock, J; (2012) Microglia, Alzheimer's disease, and complement. Int J Alzheimers Dis , 2012 983640-. 10.1155/2012/983640. Gold open access

Crehan, H; Holton, P; Wray, S; Pocock, J; Guerreiro, R; Hardy, J; (2012) Complement receptor 1 (CR1) and Alzheimer's disease. IMMUNOBIOLOGY , 217 (2) pp. 244-250. 10.1016/j.imbio.2011.07.017.

Cremades, N; Cohen, SIA; Deas, E; Abramov, AY; Chen, AY; Orte, A; Sandal, M; ... Klenerman, D; + view all (2012) Direct Observation of the Interconversion of Normal and Toxic Forms of alpha-Synuclein. CELL , 149 (5) pp. 1048-1059. 10.1016/j.cell.2012.03.037.

Curtis, HJ; Sibley, CR; Wood, MJA; (2012) Mirtrons, an emerging class of atypical miRNA. WILEY INTERDISCIPLINARY REVIEWS-RNA , 3 (5) pp. 617-632. 10.1002/wrna.1122.

D

Daborg, J; Andreasson, U; Pekna, M; Lautner, R; Hanse, E; Minthon, L; Blennow, K; ... Zetterberg, H; + view all (2012) Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION , 119 (7) pp. 789-797. 10.1007/s00702-012-0797-8.

Dale, RC; Gardiner, A; Antony, J; Houlden, H; (2012) Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY , 54 (10) pp. 958-960. 10.1111/j.1469-8749.2012.04394.x.

Davidson, GL; Murphy, SM; Polke, JM; Laura, M; Salih, MAM; Muntoni, F; Blake, J; ... Reilly, MM; + view all (2012) Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. JOURNAL OF NEUROLOGY , 259 (8) pp. 1673-1685. 10.1007/s00415-011-6397-y.

De Strooper, B; Iwatsubo, T; Wolfe, MS; (2012) Presenilins and gamma-Secretase: Structure, Function, and Role in Alzheimer Disease. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE , 2 (1) 10.1101/cshperspect.a006304.

De Strooper, B; Iwatsubo, T; Wolfe, MS; (2012) Presenilins and γ-secretase: Structure, function, and role in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine , 2 (1) 10.1101/cshperspect.a006304.

De Strooper, B; Scorrano, L; (2012) Close encounter: mitochondria, endoplasmic reticulum and Alzheimer's disease. EMBO JOURNAL , 31 (21) pp. 4095-4097. 10.1038/emboj.2012.279.

De Strooper, B; Voet, T; (2012) Alzheimer's disease: A protective mutation. Nature , 488 (7409) pp. 38-39. 10.1038/488038a.

Devine, MJ; Kaganovich, A; Ryten, M; Mamais, A; Trabzuni, D; Manzoni, C; McGoldrick, P; ... Lewis, PA; + view all (2012) Correction: Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue. PLOS ONE , 7 (1) , Article e22489. 10.1371/annotation/c12e4f9e-5aae-424b-a69f-fddf16976dc5. Green open access
file

Dihanich, S; (2012) MASL1: a neglected ROCO protein. BIOCHEMICAL SOCIETY TRANSACTIONS , 40 pp. 1090-1094. 10.1042/BST20120127.

Ding, S; Contrevas, JR; Abramov, AY; Qi, Z; Duchen, MR; (2012) Mild stress of caffeine increased mtDNA content in skeletal muscle cells: the interplay between Ca2+ transients and nitric oxide. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY , 33 (5) pp. 327-337. 10.1007/s10974-012-9318-5.

Ding, S; Riddoch-Contreras, J; Abramov, AY; Qi, Z; Duchen, MR; (2012) Erratum to: Mild stress of caffeine increased mtDNA content in skeletal muscle cells: the interplay between Ca(2+) transients and nitric oxide. J Muscle Res Cell Motil , 33 (5) 339-. 10.1007/s10974-012-9327-4.

Djamshidian, A; Lees, A; (2012) Impulsive compulsive behaviours in patients with Parkinson's disease treated with dopamine agonists. Focus on Parkinson's Disease , 23 (1) pp. 16-21.

Djamshidian, A; O'Sullivan, SS; Lees, A; Averbeck, BB; (2012) Effects of dopamine on sensitivity to social bias in Parkinson's disease. PLoS One , 7 (3) , Article e32889. 10.1371/journal.pone.0032889. Green open access
file

Djamshidian, A; O'Sullivan, SS; Lees, AJ; Averbeck, BB; (2012) Effects of dopamine on sensitivity to social bias in Parkinson's disease. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S268-S268). WILEY-BLACKWELL

Djamshidian, A; O'Sullivan, SS; Sanotsky, Y; Sharman, S; Matviyenko, Y; Foltynie, T; Michalczuk, R; ... Averbeck, BB; + view all (2012) Decision-making, impulsivity and behavioural addictions: Do Parkinson's patients jump to conclusions? MOVEMENT DISORDERS , 27 S268-S268.

Djamshidian, A; O'Sullivan, SS; Sanotsky, Y; Sharman, S; Matviyenko, Y; Foltynie, T; Michalczuk, R; ... Averbeck, BB; + view all (2012) Decision making, impulsivity, and addictions: Do Parkinson's disease patients jump to conclusions? MOVEMENT DISORDERS , 27 (9) pp. 1137-1145. 10.1002/mds.25105.

Dobricic, V; Stefanova, E; Jankovic, M; Gurunlian, N; Novakovic, I; Hardy, J; Kostic, V; (2012) Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort. NEUROBIOLOGY OF AGING , 33 (7) 10.1016/j.neurobiolaging.2011.12.007.

Doherty, KM; Noyce, AJ; Silveira-Moriyama, L; Nisbet, A; Quinn, N; Lees, AJ; (2012) Familial camptocormia: from dystonia to myopathy. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (3) pp. 350-351.

Doherty, KM; Silveira-Moriyama, L; Giladi, N; Bhatia, KP; Parton, M; Lees, AJ; (2012) Camptocormia: Don't forget muscle disease in the movement disorder clinic. Journal of Neurology , 259 (8) pp. 1752-1754. 10.1007/s00415-012-6448-z.

Doherty, KM; Silveira-Moriyama, L; Giladi, N; Bhatia, KP; Parton, M; Lees, AJ; (2012) Camptocormia: don't forget muscle disease in the movement disorder clinic. JOURNAL OF NEUROLOGY , 259 (8) pp. 1752-1754. 10.1007/s00415-012-6448-z.

Doherty, KM; Silveira-Moriyama, L; Nisbet, A; Noyce, A; Quinn, N; Parton, M; Lees, AJ; (2012) CAMPTOCORMIA: WHAT IS THE CAUSE? In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Doherty, KM; Silveira-Moriyama, L; Parkkinen, L; Healy, D; Farrell, M; Mencacci, NE; Ahmed, Z; ... Holton, JL; + view all (2012) A clinicopathological study of parkin-linked parkinsonism - A study of 5 cases and comparison with Parkinson's disease. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S453-S453). WILEY-BLACKWELL

Domijan, A-M; Kovac, S; Abramov, AY; (2012) IMPACT OF FUMONISIN B-1 ON GLUTAMATE TOXICITY AND LOW MAGNESIUM-INDUCED SEIZURE ACTIVITY IN NEURONAL PRIMARY CULTURE. NEUROSCIENCE , 202 pp. 10-16. 10.1016/j.neuroscience.2011.12.005.

Dubois, B; Tolosa, E; Katzenschlager, R; Emre, M; Lees, AJ; Schumann, G; Pourcher, E; ... Moline, ML; + view all (2012) Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study. MOVEMENT DISORDERS , 27 (10) pp. 1230-1238. 10.1002/mds.25098.

Duran, R; McNeill, A; Mehta, A; Hughes, D; Cox, T; Deegan, P; Schapira, AHV; (2012) Novel pathogenic mutations in the glucocerebrosidase locus. MOLECULAR GENETICS AND METABOLISM , 106 (4) pp. 495-497. 10.1016/j.ymgme.2012.05.006. Gold open access

Duran, R; McNeill, A; Mehta, A; Hughes, D; Cox, T; Deegan, P; Schapira, AHV; (2012) Novel pathogenic mutations in the glucocerebrosidase locus. Molecular Genetics and Metabolism , 106 (4) pp. 495-497. 10.1016/j.ymgme.2012.05.006.

E

Eadie, MJ; Scott, AEM; Lees, AJ; Woodward, M; (2012) William Gowers: the never completed third edition of the 'Bible of Neurology'. Brain , 135 (Pt 10) pp. 3178-3188. 10.1093/brain/aws181.

Eatough, V; Shaw, K; Lees, A; (2012) Banking on brains: insights of brain donor relatives and friends from an experiential perspective. Psychol Health , 27 (11) pp. 1271-1290. 10.1080/08870446.2012.669480.

Elson, JL; Sweeney, MG; Procaccio, V; Yarham, JW; Salas, A; Kong, Q-P; van der Westhuizen, FH; ... McFarland, R; + view all (2012) Toward a mtDNA locus-specific mutation database using the LOVD platform. HUMAN MUTATION , 33 (9) pp. 1352-1358. 10.1002/humu.22118.

Englund, E; Gustafson, L; Passant, U; Majounie, E; Renton, AE; Traynor, BJ; Rohrer, JD; ... Hardy, J; + view all (2012) Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion. NEUROBIOLOGY OF AGING , 33 (8) 10.1016/j.neurobiolaging.2012.02.019.

Esselens, C; Sannerud, R; Gallardo, R; Baert, V; Kaden, D; Serneels, L; De Strooper, B; ... Annaert, W; + view all (2012) Peptides based on the presenilin-APP binding domain inhibit APP processing and A beta production through interfering with the APP transmembrane domain. FASEB JOURNAL , 26 (9) pp. 3765-3778. 10.1096/fj.11-201368.

Esteras, N; Alquézar, C; Bartolomé, F; Antequera, D; Barrios, L; Carro, E; Cerdán, S; (2012) Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1). J Alzheimers Dis , 30 (2) pp. 337-353. 10.3233/JAD-2012-111967.

Esteras, N; Bartolomé, F; Alquézar, C; Antequera, D; Muñoz, Ú; Carro, E; Martín-Requero, Á; (2012) Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)]. Eur J Neurosci , 36 (5) pp. 2609-2618. 10.1111/j.1460-9568.2012.08178.x.

Esteras, N; Muñoz, Ú; Alquézar, C; Bartolomé, F; Bermejo-Pareja, F; Martín-Requero, Á; (2012) Altered calmodulin degradation and signaling in non-neuronal cells from Alzheimer's disease patients. Curr Alzheimer Res , 9 (3) pp. 267-277.

Everett, CM; Kara, E; Maresh, KE; Houlden, H; (2012) Clinical variability and L-Dopa responsive Parkinsonism in hereditary spastic paraplegia 11. JOURNAL OF NEUROLOGY , 259 (12) pp. 2726-2728. 10.1007/s00415-012-6642-z.

Everett, CM; Kara, E; Maresh, KE; Houlden, H; (2012) Clinical variability and L-Dopa responsive Parkinsonism in hereditary spastic paraplegia 11. Journal of Neurology , 259 (12) pp. 2726-2728. 10.1007/s00415-012-6642-z.

F

Fahlke, C; Berggren, U; Berglund, KJ; Zetterberg, H; Blennow, K; Engel, JA; Balldin, J; (2012) Neuroendocrine Assessment of Serotonergic, Dopaminergic, and Noradrenergic Functions in Alcohol-Dependent Individuals. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH , 36 (1) pp. 97-103. 10.1111/j.1530-0277.2011.01598.x.

Fassone, E; Taanman, JW; Sweeney, MG; Woodward, C; Hargreaves, IP; Hanna, MG; Taylor, RW; ... Rahman, S; + view all (2012) WHOLE EXOME SEQUENCING REVEALS THAT SUBUNIT MUTATIONS ARE PREVALENT IN COMPLEX I DEFICIENT LEIGH SYNDROME. In: (pp. S13-S13). SPRINGER

Fawcett, KA; Murphy, SM; Polke, JM; Wray, S; Burchell, VS; Manji, H; Quinlivan, RM; ... Houlden, H; + view all (2012) Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (12) pp. 1204-1209. 10.1136/jnnp-2012-303055.

Fawcett, KA; Murphy, SM; Polke, JM; Wray, S; Burchell, VS; Manji, H; Quinlivan, RM; ... Houlden, H; + view all (2012) Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. Journal of Neurology, Neurosurgery and Psychiatry , 83 (12) pp. 1204-1209. 10.1136/jnnp-2012-303055.

Ferrari, R; Mok, K; Moreno, JH; Cosentino, S; Goldman, J; Pietrini, P; Mayeux, R; ... Momeni, P; + view all (2012) Screening for C9ORF72 repeat expansion in FTLD. NEUROBIOLOGY OF AGING , 33 (8) 10.1016/j.neurobiolaging.2012.02.017.

Ferrari, R; Mok, K; Moreno, JH; Cosentino, S; Goldman, J; Pietrini, P; Mayeux, R; ... Momeni, P; + view all (2012) Screening for C9ORF72 repeat expansion in FTLD. Neurobiology of Aging , 33 (8) 10.1016/j.neurobiolaging.2012.02.017.

Ferrari, R; Moreno, JH; Minhajuddin, AT; O'Bryant, SE; Reisch, JS; Barber, RC; Momeni, P; (2012) Implication of common and disease specific variants in CLU, CR1, and PICALM. Neurobiology of Aging , 33 (8) 1846.e7-1846.e18. 10.1016/j.neurobiolaging.2012.01.110.

Fitzgerald, JC; Camprubi, MD; Dunn, L; Wu, H-C; Ip, NY; Kruger, R; Martins, LM; ... Plun-Favreau, H; + view all (2012) Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function. CELL DEATH AND DIFFERENTIATION , 19 (2) pp. 257-266. 10.1038/cdd.2011.90.

Flicek, P; Amode, MR; Barrell, D; Beal, K; Brent, S; Carvalho-Silva, D; Clapham, P; ... Searle, SMJ; + view all (2012) Ensembl 2012. NUCLEIC ACIDS RESEARCH , 40 (D1) D84-D90. 10.1093/nar/gkr991.

Foley, AR; Broomfield, AA; Pandraud, A; Johnson, JO; Singleton, AB; Hargreaves, IP; Land, JM; ... Muntoni, F; + view all (2012) High-dose riboflavin therapy in Brown-Vialetto-Van Laere syndrome: clinical and biochemical improvement. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S4-S4). PERGAMON-ELSEVIER SCIENCE LTD

Fonteyn, EMR; Schmitz-Hubsch, T; Verstappen, CC; Baliko, L; Boesch, S; Bunn, L; Giunti, P; ... van de Warrenburg, BPC; + view all (2012) Prospective analysis of falls in spinocerebellar ataxias. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S182-S182). WILEY-BLACKWELL

Foulds, PG; Yokota, O; Thurston, A; Davidson, Y; Ahmed, Z; Holton, J; Thompson, JC; ... Mann, DM; + view all (2012) Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Neurobiology of Disease , 45 (1) 188 - 195. 10.1016/j.nbd.2011.08.003. Green open access
file

Freeman, J; Kriston-Vizi, J; Lindenschmidt, I; Gewinner, C; Ketteler, R; (2012) Activation of autophagy limits ovarian cancer cell line growth. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , 30 S16-S16.

Friedland, RP; Shah, JJ; Farrer, LA; Vardarajan, B; Rebolledo-Mendez, JD; Mok, K; Hardy, J; (2012) Behavioral variant frontotemporal lobar degeneration with amyotrophic lateral sclerosis with a chromosome 9p21 hexanucleotide repeat. Front Neurol , 3 136-. 10.3389/fneur.2012.00136. Gold open access

G

Gallagher, DA; Goetz, CG; Stebbins, G; Lees, AJ; Schrag, A; (2012) Validation of the MDS-UPDRS Part I for Nonmotor Symptoms in Parkinson's Disease. MOVEMENT DISORDERS , 27 (1) pp. 79-83. 10.1002/mds.23939.

Gallagher, DA; Goetz, CG; Stebbins, G; Lees, AJ; Schrag, A; (2012) Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Movement Disorders , 27 (1) pp. 79-83. 10.1002/mds.23939.

Gandhi, S; Abramov, AY; (2012) Mechanism of oxidative stress in neurodegeneration. Oxidative Medicine and Cellular Longevity 10.1155/2012/428010. Gold open access

Gandhi, S; Vaarmann, A; Yao, Z; Duchen, MR; Wood, NW; Abramov, AY; (2012) Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease. PLoS One , 7 (5) , Article e37564. 10.1371/journal.pone.0037564. Green open access
file

Gandhi, S; Wood, NW; (2012) The human genome project - what it really means and where next. In: Neurogenetics: A Guide for Clinicians. (pp. 1-5).

Gardiner, A; Bhatia, KP; Stameou, M; Dale, RC; Kurian, M; Schneider, S; Wali, GM; ... Houlden, H; + view all (2012) Prrt2 gene mutations: From paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. MOVEMENT DISORDERS , 27 S448-S448.

Gardiner, A; Jaffer, F; Pittman, A; Gibbons, V; Wood, N; Hanna, M; Houlden, H; (2012) Next Generation Sequencing of Ion Channels in Neurological disorders. In: (Proceedings) British Human Genetics Conference. (pp. S119-S119). BMJ PUBLISHING GROUP

Gardiner, A; Kullmann, D; Wood, N; Ptacek, L; Houlden, H; Hanna, M; (2012) Episodic muscle and brain channels: Analysis of the PRRT2 gene and screening of a muscle channel panel. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S17-S17). PERGAMON-ELSEVIER SCIENCE LTD

Gardiner, AR; Bhatia, KP; Stamelou, M; Dale, RC; Kurian, MA; Schneider, SA; Wali, GM; ... Houlden, H; + view all (2012) PRRT2 gene mutations From paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. NEUROLOGY , 79 (21) pp. 2115-2121.

Gaujoux-Viala, C; Knevel, R; Mandl, P; Nagy, G; Frank, M; Machado, P; Hatemi, G; ... Gossec, L; + view all (2012) Who are the young professionals working in the field of rheumatology in Europe and what are their needs? An EMEUNET (EMerging EUlar NETwork) survey. ANNALS OF THE RHEUMATIC DISEASES , 71 (8) pp. 1432-1433. 10.1136/annrheumdis-2011-201266.

Gegg, ME; Burke, D; Heales, SJR; Cooper, JM; Hardy, J; Wood, NW; Schapira, AHV; (2012) Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. ANNALS OF NEUROLOGY , 72 (3) pp. 455-463. 10.1002/ana.23614.

Gerrish, A; Russo, G; Richards, A; Moskvina, V; Ivanov, D; Harold, D; Sims, R; ... Williams, J; + view all (2012) The Role of Variation at A beta PP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE , 28 (2) pp. 377-387. 10.3233/JAD-2011-110824.

Gerrish, A; Russo, G; Richards, A; Moskvina, V; Ivanov, D; Harold, D; Sims, R; ... Holmans, PA; + view all (2012) The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. Journal of Alzheimer's Disease , 28 (2) pp. 377-387. 10.3233/JAD-2011-110824.

Gibbons, V; Labrum, RW; Haworth, A; Sweeney, MG; Wood, NW; Houlden, H; Hanna, MG; (2012) Episodic ataxia type 2-mutation analysis and screening recommendations. In: (Proceedings) British Human Genetics Conference. (pp. S87-S87). BMJ PUBLISHING GROUP

Gisslen, M; Fuchs, D; Hagberg, L; Svennerholm, B; Zetterberg, H; (2012) Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , 44 (12) pp. 997-1000. 10.3109/00365548.2012.690526.

Giunti, P; Houlden, H; Gardner-Thorpe, C; Worth, PF; Johnson, J; Hilton, DA; Revesz, T; ... Wood, NW; + view all (2012) Spinocerebellar ataxia type 11. In: UNSPECIFIED (pp. 521-534).

Giunti, P; Nethisinghe, S; Clayton, LM; Vermeer, S; Chapple, JP; Reilly, MM; Bremner, F; (2012) DETECTING RETINAL CHANGES IN AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY (ARSACS) USING OPTICAL COHERENCE TOMOGRAPHY (OCT). In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Glass, P; Lees, A; Bacellar, A; Zijlmans, J; Katzenschlager, R; Silveira-Moriyama, L; (2012) Clinical Features of Vascular Parkinsonism in Pathologically Confirmed Cases. In: (Proceedings) 64th Annual Meeting of the American-Academy-of-Neurology (AAN). LIPPINCOTT WILLIAMS & WILKINS

Glass, PG; Lees, AJ; Bacellar, A; Zijlmans, J; Katzenschlager, R; Silveira-Moriyama, L; (2012) The clinical features of pathologically confirmed vascular Parkinsonism. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (10) pp. 1027-1029. 10.1136/jnnp-2012-302828.

Glass, PG; Lees, AJ; Mathias, C; Mason, L; Best, C; Williams, DR; Katzenschlager, R; (2012) Olfaction in pathologically proven patients with multiple system atrophy. Movement Disorders , 27 (2) pp. 327-328. 10.1002/mds.23972.

Glodzik, L; Mosconi, L; Tsui, W; de Santi, S; Zinkowski, R; Pirraglia, E; Rich, KE; ... de Leon, MJ; + view all (2012) Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly. NEUROBIOLOGY OF AGING , 33 (7) pp. 1215-1227. 10.1016/j.neurobiolaging.2011.02.012.

Goate, A; Hardy, J; (2012) Twenty years of Alzheimer's disease-causing mutations. JOURNAL OF NEUROCHEMISTRY , 120 pp. 3-8. 10.1111/j.1471-4159.2011.07575.x.

Graves, T; Cha, Y-H; Hahn, A; Barohn, R; Amato, A; Griggs, R; Bundy, B; ... Hanna, M; + view all (2012) Episodic Ataxia Type 1: Characterization of the Disease and Its Effect on Quality of Life. In: (Proceedings) 64th Annual Meeting of the American-Academy-of-Neurology (AAN). LIPPINCOTT WILLIAMS & WILKINS

Graves, T; Fialho, D; Smith, S; Cha, Y-H; Amato, A; Griggs, R; Bundy, B; ... Hanna, M; + view all (2012) EEG Abnormalities in the Episodic Ataxias. In: (Proceedings) 64th Annual Meeting of the American-Academy-of-Neurology (AAN). LIPPINCOTT WILLIAMS & WILKINS

Gray, A; Nirmalananthan, N; Malik, B; Dick, J; Hanna, M; Greensmith, L; (2012) Targeting the endogenous stress response in a mouse model of SBMA. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S12-S12). PERGAMON-ELSEVIER SCIENCE LTD

Guergueltcheva, V; Mueller, JS; Dusl, M; Senderek, J; Oldfors, A; Lindbergh, C; Maxwell, S; ... Lochmueller, H; + view all (2012) Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations. JOURNAL OF NEUROLOGY , 259 (5) pp. 838-850. 10.1007/s00415-011-6262-z.

Guerreiro, R; Kara, E; Le Ber, I; Bras, J; Rohrer, J; Taipa, R; Lashley, T; ... Houlden, H; + view all (2012) Genetic analysis of inherited leukodystrophies: genotype phenotype correlations in the CSF1R gene. In: (Proceedings) 8th International Conference on Frontotemporal Dementias. (pp. p. 9). KARGER

Guerreiro, R; Kara, E; Le Ber, I; Bras, J; Rohrer, J; Taipa, R; Lashley, T; ... Houlden, H; + view all (2012) Genetic analysis of inherited leukodystrophies: genotype phenotype correlations in the CSF1R gene. In: (Proceedings) 8th International Conference on Frontotemporal Dementias. (pp. p. 257). KARGER

Guerreiro, RJ; Gustafson, DR; Hardy, J; (2012) The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiology of Disease , 33 (3) 437 - 456. 10.1016/j.neurobiolaging.2010.03.025. Green open access
file

Guerreiro, RJ; Hardy, J; (2012) TOMM40 Association With Alzheimer Disease Tales of APOE and Linkage Disequilibrium. ARCHIVES OF NEUROLOGY , 69 (10) pp. 1243-1244. 10.1001/archneurol.2012.1935.

Guerreiro, RJ; Hardy, J; (2012) TOMM40 association with Alzheimer disease: tales of APOE and linkage disequilibrium. Arch Neurol , 69 (10) pp. 1243-1244. 10.1001/archneurol.2012.1935.

Guerreiro, RJ; Lohmann, E; Brás, JM; Gibbs, JR; Rohrer, JD; Gurunlian, N; Dursun, B; ... Hardy, J; + view all (2012) Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia-like Syndrome Without Bone Involvement. Arch Neurol pp. 1-7. 10.1001/archneurol.2013.579.

Guerreiro, RJ; Lohmann, E; Kinsella, E; Bras, JM; Luu, N; Gurunlian, N; Dursun, B; ... Singleton, A; + view all (2012) Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease. NEUROBIOLOGY OF AGING , 33 (5) 10.1016/j.neurobiolaging.2011.10.009.

Guix, FX; Wahle, T; Vennekens, K; Snellinx, A; Chavez-Gutierrez, L; Ill-Raga, G; Ramos-Fernandez, E; ... De Strooper, B; + view all (2012) Modification of gamma-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease. EMBO MOLECULAR MEDICINE , 4 (7) pp. 660-673. 10.1002/emmm.201200243.

Gupta, K; Patani, R; Baxter, P; Serio, A; Story, D; Tsujita, T; Hayes, JD; ... Chandran, S; + view all (2012) Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. CELL DEATH AND DIFFERENTIATION , 19 (5) pp. 779-787. 10.1038/cdd.2011.154.

Gustavsson, J; Mehlig, K; Leander, K; Strandhagen, E; Bjorck, L; Thelle, DS; Lissner, L; ... Nyberg, F; + view all (2012) Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women. ATHEROSCLEROSIS , 220 (2) pp. 486-492. 10.1016/j.atherosclerosis.2011.10.011.

H

Haack, TB; Hogarth, P; Kruer, MC; Gregory, A; Wieland, T; Schwarzmayr, T; Graf, E; ... Hayflick, SJ; + view all (2012) Exome Sequencing Reveals De Novo WDR45 Mutations Causing a Phenotypically Distinct, X-Linked Dominant Form of NBIA. AMERICAN JOURNAL OF HUMAN GENETICS , 91 (6) pp. 1144-1149. 10.1016/j.ajhg.2012.10.019.

Haack, TB; Hogarth, P; Kruer, MC; Gregory, A; Wieland, T; Schwarzmayr, T; Graf, E; ... Hayflick, SJ; + view all (2012) Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. American Journal of Human Genetics , 91 (6) pp. 1144-1149. 10.1016/j.ajhg.2012.10.019.

Hall, S; Ohrfelt, A; Constantinescu, R; Andreasson, U; Surova, Y; Bostrom, F; Nilsson, C; ... Hansson, O; + view all (2012) Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders. ARCHIVES OF NEUROLOGY , 69 (11) pp. 1445-1452. 10.1001/archneurol.2012.1654.

Hanna, MG; Kullmann, DM; (2012) Channelopathies. pp. 121-135. 10.1017/CBO9781139087711.009.

Hansson, O; Stomrud, E; Vanmechelen, E; Ostling, S; Gustafson, DR; Zetterberg, H; Blennow, K; (2012) Evaluation of Plasma A beta as Predictor of Alzheimer's Disease in Older Individuals Without Dementia: A Population-Based Study. JOURNAL OF ALZHEIMERS DISEASE , 28 (1) pp. 231-238. 10.3233/JAD-2011-111418.

Hardy, J; (2012) Alzheimer’s disease and related dementias. pp. 17-31. 10.1017/CBO9781139087711.003.

Hardy, J; (2012) CSF biomarking for diagnosis and treatment assessment in neurodegeneration. JOURNAL OF NEUROCHEMISTRY , 123 (3) pp. 339-341. 10.1111/j.1471-4159.2012.07928.x.

Hardy, J; (2012) Genetic analysis of disease in the era of whole genome analysis and public databases. NEUROBIOLOGY OF AGING , 33 (4) p. 635. 10.1016/j.neurobiolaging.2011.12.039.

Hardy, J; Revesz, T; (2012) The Spread of Neurodegenerative Disease. NEW ENGLAND JOURNAL OF MEDICINE , 366 (22) pp. 2126-2128.

Hernandez, DG; Nalls, MA; Moore, M; Chong, S; Dillman, A; Trabzuni, D; Gibbs, JR; ... Cookson, MR; + view all (2012) Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain. Neurobiology of Disease , 47 (1) 20 - 28. 10.1016/j.nbd.2012.03.020. Green open access
file

Hernandez, DG; Nalls, MA; Ylikotila, P; Keller, M; Hardy, JA; Majamaa, K; Singleton, AB; (2012) Genome Wide Assessment of Young Onset Parkinson's Disease from Finland. PLOS ONE , 7 (7) , Article e41859. 10.1371/journal.pone.0041859. Green open access
file

Hersheson, J; Haworth, A; Houlden, H; (2012) The inherited ataxias: Genetic heterogeneity, mutation databases, and future directions in research and clinical diagnostics. HUMAN MUTATION , 33 (9) pp. 1324-1332. 10.1002/humu.22132.

Hersheson, J; Hersheson, J; Pittman, A; Houlden, H; (2012) Developing a NGS screening panel for dominant cerebellar ataxia. In: (Proceedings) British Human Genetics Conference. (pp. S120-S120). BMJ PUBLISHING GROUP

Hersheson, J; Pittman, A; Houlden, H; (2012) Piloting targeted next-generation sequencing for screening the known ataxia genes: The next step for all diagnostic laboratories. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S456-S457). WILEY-BLACKWELL

Hersheson, JS; Mencacci, NE; Giunti, P; Wood, N; Houlden, H; (2012) Screening a UK cohort for spinocerebellar ataxia type 36 (SCA36). In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S183-S183). WILEY-BLACKWELL

Heslegrave, AJ; Kapoor, RR; Eaton, S; Chadefaux, B; Akcay, T; Simsek, E; Flanagan, SE; ... Hussain, K; + view all (2012) Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA Dehydrogenase. ORPHANET JOURNAL OF RARE DISEASES , 7 (ARTN 25) 10.1186/1750-1172-7-25. Gold open access

Hiscock, A; Dewar, L; Parton, M; Machado, P; Hanna, M; Ramdharry, G; (2012) Frequency and circumstances of falls in people with Inclusion Body Myositis. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S30-S31). PERGAMON-ELSEVIER SCIENCE LTD

Hobart, JC; Cano, SJ; Warner, TT; Thompson, AJ; (2012) What sample sizes for reliability and validity studies in neurology? Journal of Neurology pp. 1-14.

Hobart, JC; Cano, SJ; Warner, TT; Thompson, AJ; (2012) What sample sizes for reliability and validity studies in neurology? JOURNAL OF NEUROLOGY , 259 (12) pp. 2681-2694. 10.1007/s00415-012-6570-y.

Hollingworth, P; Sweet, R; Sims, R; Harold, D; Russo, G; Abraham, R; Stretton, A; ... Williams, J; + view all (2012) Genome-wide association study of Alzheimer's disease with psychotic symptoms. MOLECULAR PSYCHIATRY , 17 (12) pp. 1316-1327. 10.1038/mp.2011.125.

Holmstrom, KM; Baird, L; Dinkova-Kostova, AT; Abramov, AY; (2012) Nrf2 Controls Mitochondrial Bioenergetics. BIOPHYSICAL JOURNAL , 102 (3) 573A-573A.

Horga, A; Rayan, DLR; Haworth, A; Matthews, E; Fialho, D; Sud, R; Portaro, S; ... Hanna, MG; + view all (2012) Prevalence study of skeletal muscle channelopathies in England. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S17-S17). PERGAMON-ELSEVIER SCIENCE LTD

Horga, A; Rayan, DLR; Matthews, E; Fialho, D; Sud, R; Haworth, A; Portaro, S; ... Hanna, MG; + view all (2012) PREVALENCE STUDY OF SKELETAL MUSCLE CHANNELOPATHIES IN ENGLAND. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Houlden, H; (2012) A Commentary on 'Four novel C20ORF54 mutations identified in Brown-Vialetto-Van Laere syndrome patients.'. JOURNAL OF HUMAN GENETICS , 57 (9) p. 555. 10.1038/jhg.2012.88.

Houlden, H; (2012) Extending the clinical spectrum of pain channelopathies. BRAIN , 135 pp. 313-316. 10.1093/brain/aws007.

Houlden, H; (2012) Sniffing out the cerebellum. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (10) pp. 952-953. 10.1136/jnnp-2012-303136.

Houlden, H; Singleton, AB; (2012) The genetics and neuropathology of Parkinson's disease. ACTA NEUROPATHOLOGICA , 124 (3) pp. 325-338. 10.1007/s00401-012-1013-5.

Huey, ED; Ferrari, R; Moreno, JH; Jensen, C; Morris, CM; Potocnik, F; Kalaria, RN; ... Momeni, P; + view all (2012) FUS and TDP43 genetic variability in FTD and CBS. NEUROBIOLOGY OF AGING , 33 (5) 10.1016/j.neurobiolaging.2011.08.004.

Hölttä, M; Zetterberg, H; Mirgorodskaya, E; Mattsson, N; Blennow, K; Gobom, J; (2012) Peptidome analysis of cerebrospinal fluid by LC-MALDI MS. PLoS One , 7 (8) , Article e42555. 10.1371/journal.pone.0042555. Green open access
file

I

Ince-Dunn, G; Okano, HJ; Jensen, KB; Park, W-Y; Zhong, R; Ule, J; Mele, A; ... Darnell, RB; + view all (2012) Neuronal Elav-like (Hu) Proteins Regulate RNA Splicing and Abundance to Control Glutamate Levels and Neuronal Excitability. NEURON , 75 (6) pp. 1067-1080. 10.1016/j.neuron.2012.07.009.

Ip, L; Cia-Viciano, F; Spanswick, V; Pouigiannis, G; Cantley, L; Hartley, J; Hochhauser, D; (2012) Loss of the tumour suppressor inositol polyphosphate 4-phosphatase type II in ovarian cancer-implications for therapy. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , 30 S19-S19.

J

Jacobi, H; Hauser, T-K; Giunti, P; Globas, C; Bauer, P; Schmitz-Huebsch, T; Baliko, L; ... Klockgether, T; + view all (2012) Spinocerebellar Ataxia Types 1, 2, 3 and 6: the Clinical Spectrum of Ataxia and Morphometric Brainstem and Cerebellar Findings. CEREBELLUM , 11 (1) pp. 155-166. 10.1007/s12311-011-0292-z.

Jaffer, F; Graves, T; Gibbons, V; Gardiner, A; Hersheson, J; Hanna, M; Houlden, H; (2012) Episodic ataxia: screening candidate genes and genetic analysis of families. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S17-S17). PERGAMON-ELSEVIER SCIENCE LTD

Jaffer, F; Reilly, MM; Quinlivan, RR; Muntoni, F; Orrell, R; Wraige, E; Saha, R; ... Hanna, M; + view all (2012) AVOIDING UNPLANNED HOSPITAL ADMISSIONS IN PATIENTS WITH NEUROMUSCULAR DISEASES: A REGIONAL COLLABORATIVE AUDIT OF HOSPITAL ADMISSIONS. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. BMJ PUBLISHING GROUP

Januario, F; Almeida, J; Serra, S; Amaral, C; Machado, P; Rodrigues, LA; (2012) Characterization of Patients with Ankylosing Spondylitis in Hidrokinesitherapy - A Multidimensional Assessment. ACTA MEDICA PORTUGUESA , 25 (5) pp. 301-307.

Jebelli, JD; Dihanich, S; Civiero, L; Manzoni, C; Greggio, E; Lewis, PA; (2012) GTP binding and intramolecular regulation by the ROC domain of Death Associated Protein Kinase 1. SCIENTIFIC REPORTS , 2 (ARTN 695) 10.1038/srep00695. Gold open access

Johnson, JO; Gibbs, JR; Megarbane, A; Urtizberea, JA; Hernandez, DG; Foley, AR; Arepalli, S; ... Singleton, AB; + view all (2012) Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. BRAIN , 135 pp. 2875-2882. 10.1093/brain/aws161.

Jonsson, M; Zetterberg, H; Rolstad, S; Edman, A; Gouw, AA; Bjerke, M; Lind, K; ... Wallin, A; + view all (2012) Low Cerebrospinal Fluid Sulfatide Predicts Progression of White Matter Lesions - The LADIS Study. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS , 34 (1) pp. 61-67. 10.1159/000341576.

K

Kamynina, AV; Holmstrom, KM; Koroev, DO; Volpina, OM; Abramov, AY; (2012) Anti-peptide antibodies to synthetic fragments of alpha7-subunit acetylcholine receptor or prion protein protect cells against beta-amyloid toxicity. JOURNAL OF PEPTIDE SCIENCE , 18 S136-S136.

Kara, E; Ling, H; Pittman, AM; Shaw, K; de Silva, R; Simone, R; Holton, JL; ... Revesz, T; + view all (2012) The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobioly of Aging , 33 (9) 2231.e7 - 2231.e14. 10.1016/j.neurobiolaging.2012.04.006. Green open access
file

Kara, E; Xiromerisiou, G; Paudel, R; Revesz, T; Holton, J; Lees, A; Wood, N; ... Houlden, H; + view all (2012) Comprehensive genetic investigation of NBIA and complex dystonia-parkinsonism. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S459-S459). WILEY-BLACKWELL

Keenan, BT; Shulman, JM; Chibnik, LB; Raj, T; Tran, D; Sabuncu, MR; Allen, AN; ... De Jager, PL; + view all (2012) A coding variant in CR1 interacts with APOE-?4 to influence cognitive decline. HUMAN MOLECULAR GENETICS , 21 (10) pp. 2377-2388. 10.1093/hmg/dds054.

Keller, MF; Saad, M; Bras, J; Bettella, F; Nicolaou, N; Simon-Sanchez, J; Mittag, F; ... Nalls, MA; + view all (2012) Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. HUMAN MOLECULAR GENETICS , 21 (22) pp. 4996-5009. 10.1093/hmg/dds335.

Kilarski, LL; Pearson, JP; Newsway, V; Majounie, E; Knipe, MDW; Misbahuddin, A; Chinnery, PF; ... Morris, HR; + view all (2012) Systematic Review and UK-Based Study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. MOVEMENT DISORDERS , 27 (12) pp. 1522-1529. 10.1002/mds.25132.

Koenig, J; Zarnack, K; Luscombe, NM; Ule, J; (2012) Protein-RNA interactions: new genomic technologies and perspectives. NATURE REVIEWS GENETICS , 13 (2) pp. 77-83. 10.1038/nrg3141.

Kojovic, M; Sheerin, U; Rubio-Agusti, I; Bras, J; Wood, N; Houlden, H; Hardy, J; (2012) Young Onset Parkinson's Disease Due to Homozygous Duplication of SNCA in a Consanguineous Family from Pakistan. In: (Proceedings) 64th Annual Meeting of the American-Academy-of-Neurology (AAN). LIPPINCOTT WILLIAMS & WILKINS

Kojovic, M; Sheerin, UM; Rubio-Agusti, I; Saha, A; Bras, J; Gibbons, V; Palmer, R; ... Bhatia, KP; + view all (2012) Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family. Mov Disord , 27 (14) pp. 1829-1830. 10.1002/mds.25199. Green open access
file

Kojovic, M; Sheerin, UM; Rubio-Agusti, I; Saha, A; Bras, J; Gibbons, V; Palmer, R; ... Bhatia, KP; + view all (2012) Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family. Movement disorders : official journal of the Movement Disorder Society , 27 (14) pp. 1827-1829. 10.1002/mds.25114.

Korkodilos, M; Hajioff, S; Gardner, C; Overett, S; Ibrahim, S; Jaffer, F; Hanna, MG; (2012) Audit of unplanned admissions in neuromuscular patients: a collaborative audit. Audit, Information and Analysis Unit / London Specialised Commissioning Group / MRC Centre for Neuromuscular Diseases: United Kingdom. Green open access
file

Kosicek, M; Zetterberg, H; Andreasen, N; Peter-Katalinic, J; Hecimovic, S; (2012) Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease. NEUROSCIENCE LETTERS , 516 (2) pp. 302-305. 10.1016/j.neulet.2012.04.019.

Koutsis, G; Karadima, G; Pandraud, A; Sweeney, MG; Paudel, R; Houlden, H; Wood, NW; (2012) Genetic screening of Greek patients with Huntington's disease phenocopies identifies an SCA8 expansion. JOURNAL OF NEUROLOGY , 259 (9) pp. 1874-1878. 10.1007/s00415-012-6430-9.

Koutsis, G; Mok, K; Schottlaender, L; Polke, J; Panas, M; Houlden, H; (2012) High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. In: (Proceedings) 16th Congress of the European-Federation-of-Neurological-Societies (EFNS). (pp. p. 726). WILEY-BLACKWELL

Koutsis, G; Pandraud, A; Karadima, G; Panas, M; Floroskoufi, P; Wood, NW; Houlden, H; (2012) Mutational analysis of PMP22, EGR2, LITAF and NEFL in Greek Charcot-Marie-Tooth type 1 patients. In: (Proceedings) 16th Congress of the European-Federation-of-Neurological-Societies (EFNS). (pp. p. 729). WILEY-BLACKWELL

Koutsis, G; Pandraud, A; Polke, JM; Wood, NW; Panas, M; Karadima, G; Houlden, H; (2012) Novel peripheral myelin protein 22 (PMP22) micromutations associated with variable phenotypes in Greek patients with Charcot-Marie-Tooth disease. BRAIN , 135 (ARTN e21) 10.1093/brain/aws034.

Koutsis, G; Pemble, S; Sweeney, MG; Paudel, R; Wood, NW; Panas, M; Kladi, A; (2012) Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia. JOURNAL OF THE NEUROLOGICAL SCIENCES , 318 (1-2) pp. 178-180. 10.1016/j.jns.2012.03.019.

Koutsis, G; Pemble, S; Sweeney, MG; Paudel, R; Wood, NW; Panas, M; Kladi, A; (2012) Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia. In: (Proceedings) 16th Congress of the European-Federation-of-Neurological-Societies (EFNS). (pp. p. 731). WILEY-BLACKWELL

Kovac, S; Domijan, A-M; Walker, MC; Abramov, AY; (2012) Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death. JOURNAL OF CELL SCIENCE , 125 (7) pp. 1796-1806. 10.1242/jcs.099176.

Kovac, S; Hamil, N; Williams, S; Domijan, A; Walker, MC; Abramov, AY; (2012) SEIZURE ACTIVITY GENERATES CALCIUM-INDEPENDENT REACTIVE OXYGEN SPECIES VIA NADPH OXIDASE AND XANTHINE OXIDASE. In: (Proceedings) 10th European Congress on Epileptology. (pp. p. 178). WILEY-BLACKWELL

Kruczyk, M; Zetterberg, H; Hansson, O; Rolstad, S; Minthon, L; Wallin, A; Blennow, K; ... Andersson, MG; + view all (2012) Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment. JOURNAL OF NEURAL TRANSMISSION , 119 (7) pp. 821-831. 10.1007/s00702-012-0812-0.

Kruer, M; Jepperson, T; Steiner, R; Russman, B; Blasco, P; Fan, G; Pollock, J; ... Houlden, H; + view all (2012) Mutations in ADD3 Lead to Inherited Forms of Spastic Diplegia and Spastic Quadriplegia. In: (Proceedings) 137th Annual Meeting of the American-Neurological-Association (ANA). (pp. S218-S218). WILEY-BLACKWELL

Kruer, MC; Boddaert, N; Schneider, SA; Houlden, H; Bhatia, KP; Gregory, A; Anderson, JC; ... Hayflick, SJ; + view all (2012) Neuroimaging Features of Neurodegeneration with Brain Iron Accumulation. AMERICAN JOURNAL OF NEURORADIOLOGY , 33 (3) pp. 407-414. 10.3174/ajnr.A2677.

Kruer, MC; Paudel, R; Wagoner, W; Sanford, L; Kara, E; Gregory, A; Foltynie, T; ... Houlden, H; + view all (2012) Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. NEUROSCIENCE LETTERS , 523 (1) pp. 35-38. 10.1016/j.neulet.2012.06.036.

Kruer, MC; Paudel, R; Wagoner, W; Sanford, L; Kara, E; Gregory, A; Foltynie, T; ... Houlden, H; + view all (2012) Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. Neuroscience Letters , 523 (1) pp. 35-38. 10.1016/j.neulet.2012.06.036.

Krut, JJ; Zetterberg, H; Blennow, K; Cinque, P; Hagberg, L; Price, RW; Studahl, M; (2012) Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. Journal of Neurology pp. 1-7.

König, J; McGlincy, NJ; Ule, J; (2012) Analysis of Protein-RNA Interactions with Single-Nucleotide Resolution Using iCLIP and Next-Generation Sequencing. pp. 153-169. 10.1002/9783527644582.ch10.

L

Lace, G; Ince, PG; Brayne, C; Savva, GM; Matthews, FE; de Silva, R; Simpson, JE; (2012) Mesial Temporal Astrocyte Tau Pathology in the MRC-CFAS Ageing Brain Cohort. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS , 34 (1) pp. 15-24. 10.1159/000341581.

Laires, PA; Canhao, H; Araujo, D; Fonseca, JE; Machado, P; Mourao, AF; Ramiro, S; ... Branco, JC; + view all (2012) CoReumaPt Protocol: the Portuguese Cohort of Rheumatic Diseases. ACTA REUMATOLOGICA PORTUGUESA , 37 (1) pp. 18-24.

Landgren, S; von Otter, M; Palmer, MS; Zetterstrom, C; Nilsson, S; Skoog, I; Gustafson, DR; ... Kettunen, P; + view all (2012) A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION , 119 (7) pp. 833-842. 10.1007/s00702-012-0823-x.

Laura, M; Murphy, SM; Hornemann, T; Bode, H; Polke, J; Blake, J; Houlden, H; (2012) Hereditary sensory neuropathy type 1: correlation of severity and plasma atypical deoxy-sphyngoid bases. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S18-S18). PERGAMON-ELSEVIER SCIENCE LTD

Lee, H-Y; Huang, Y; Bruneau, N; Roll, P; Roberson, EDO; Hermann, M; Quinn, E; ... Ptacek, LJ; + view all (2012) Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions. CELL REPORTS , 1 (1) pp. 2-12. 10.1016/j.celrep.2011.11.001.

Lee, H-Y; Huang, Y; Bruneau, N; Roll, P; Roberson, EDO; Hermann, M; Quinn, E; ... Ptacek, LJ; + view all (2012) Mutations in the Novel Protein PRRT2 Cause Infantile Convulsions with Paroxysmal Kinesigenic Dyskinesia. In: (Proceedings) 137th Annual Meeting of the American-Neurological-Association (ANA). (pp. S59-S59). WILEY-BLACKWELL

Lee, H-Y; Huang, Y; Edwards, R; Hanna, M; Bowcock, A; Szepetowski, P; Fu, Y-H; (2012) Mutations in the Novel Protein PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions. In: (Proceedings) 64th Annual Meeting of the American-Academy-of-Neurology (AAN). LIPPINCOTT WILLIAMS & WILKINS

Lee, H-Y; Huang, Y; Edwards, R; Hanna, M; Bowcock, A; Szepetowski, P; Fu, Y-H; (2012) Mutations in the Novel Protein PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions. NEUROLOGY , 78 Gold open access

Lees, A; (2012) East meets west to provide the best for PD patients. Focus on Parkinson's Disease , 23 (1) 2-.

Lees, A; (2012) Two decades of evolving care with pump therapies - What have we learned? European Neurological Review , 7 (SUPPL.1) pp. 5-7.

Lees, A; Costa, R; Oliveira, C; Lopes, N; Nunes, T; Soares-da-Silva, P; (2012) Design of a double-blind, placebo-controlled, phase-III trial in patients with Parkinson's disease and end-of-dose motor fluctuations: opicapone superiority vs. placebo. In: (pp. p. 695).

Lees, A; Costa, R; Oliveira, C; Lopes, N; Nunes, T; Soares-da-Silva, P; (2012) The design of a double-blind, placebo-controlled, multi-national phase-III trial in patients with Parkinson's disease and end-of-dose motor fluctuations: Opicapone superiority vs. placebo. In: (pp. S127-S127).

Lees, A; Fahn, S; Eggert, KM; Jankovic, J; Lang, A; Micheli, F; Maral Mouradian, M; ... Kumar, D; + view all (2012) Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Movement Disorders , 27 (2) pp. 284-288. 10.1002/mds.23983.

Lees, A; Fahn, S; Eggert, KM; Jankovic, J; Lang, A; Micheli, F; Mouradian, MM; ... Kumar, D; + view all (2012) Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Mov Disord , 27 (2) pp. 284-288. 10.1002/mds.23983.

Lees, AJ; (2012) Impact Commentaries. A modern perspective on the top 100 cited JNNP papers of all time: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease: accuracy of clinical diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry , 83 (10) pp. 954-955. 10.1136/jnnp-2012-302969.

Lees, AJ; (2012) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry , 83 (10) pp. 954-955. 10.1136/jnnp-2012-302969.

Lees, AJ; Woodward, RMP; Scott, AEM; Eadie, MJ; (2012) W R Gowers 1895: two unpublished post-graduate lectures. Brain , 135 (Pt 10) pp. 3165-3177. 10.1093/brain/aws029.

Lescai, F; Bonfiglio, S; Bacchelli, C; Chanudet, E; Waters, A; Sisodiya, SM; Kasperavičiūtė, D; ... Stupka, E; + view all (2012) Characterisation and validation of insertions and deletions in 173 patient exomes. PLoS One , 7 (12) , Article e51292. 10.1371/journal.pone.0051292. Green open access
file

Lill, CM; Roehr, JT; McQueen, MB; Kavvoura, FK; Bagade, S; Schjeide, B-MM; Schjeide, LM; ... WTCCC2, ; + view all (2012) Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database. PLOS GENETICS , 8 (3) , Article e1002548. 10.1371/journal.pgen.1002548. Green open access
file

Lin, MT; Cantuti-Castelvetri, I; Lees, AJ; Beal, MF; Simon, DK; (2012) Reply. Annals of Neurology , 72 (5) pp. 823-824. 10.1002/ana.23739.

Lin, MT; Cantuti-Castelvetri, I; Lees, AJ; Beal, MF; Simon, DK; (2012) Somatic Mitochondrial DNA Mutations and Parkinsonism Reply. ANNALS OF NEUROLOGY , 72 (5) pp. 823-824. 10.1002/ana.23739.

Lin, MT; Cantuti-Castelvetri, I; Zheng, K; Jackson, KE; Tan, YB; Arzberger, T; Lees, AJ; ... Simon, DK; + view all (2012) Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann Neurol , 71 (6) pp. 850-854. 10.1002/ana.23568.

Ling, H; Massey, L; Lees, A; Brown, P; Day, B; (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. MOVEMENT DISORDERS , 27 S384-S385.

Ling, H; Massey, LA; Lees, AJ; Brown, P; Day, BL; (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. BRAIN , 135 pp. 1141-1153. 10.1093/brain/aws038.

Ling, H; Massey, LA; Lees, AJ; Brown, P; Day, BL; (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. Brain , 135 (Pt 4) 1141 - 1153. 10.1093/brain/aws038.

Ling, H; Petrovic, I; Day, BL; Lees, AJ; (2012) Smoking-induced transient motor deterioration in a levodopa-treated patient with Parkinson's disease. JOURNAL OF NEUROLOGY , 259 (11) pp. 2419-2423. 10.1007/s00415-012-6515-5.

Ling, H; Petrovic, I; Day, BL; Lees, AJ; (2012) Smoking-induced transient motor deterioration in a levodopa-treated patient with Parkinson's disease. Journal of Neurology , 259 (11) pp. 2419-2423. 10.1007/s00415-012-6515-5.

Ling, H; de Silva, R; Courtney, R; Massey, L; Bajaj, N; Lowe, J; Holton, J; ... Revesz, T; + view all (2012) Clinicopathological study of progressive supranuclear palsy presenting with corticobasal syndrome. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S384-S384). WILEY-BLACKWELL

Ling, H; de Silva, R; Massey, L; Bajaj, N; Lowe, J; Holton, J; Lees, A; (2012) Clinicopathological correlation of progressive supranuclear palsy presenting with corticobasal syndrome. In: (Proceedings) 16th Congress of the European-Federation-of-Neurological-Societies (EFNS). (pp. p. 290). WILEY-BLACKWELL

Liu, Y-T; Laura, M; Wood, N; Reilly, MM; Houlden, H; (2012) Mutations of the kinesin family member 5A (KIF5A) gene in patients with pure or complex Charcot-Marie-Tooth type 2 (CMT2). In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S18-S18). PERGAMON-ELSEVIER SCIENCE LTD

Liu, Y-T; Pittman, A; Hughes, D; Polke, JM; Sweeney, MG; Houlden, H; Reilly, MM; (2012) Application of targeted resequencing panels in genetic diagnosis of Charcot-Marie-Tooth disease. In: (Proceedings) British Human Genetics Conference. (pp. S119-S119). BMJ PUBLISHING GROUP

Lo, C; Shorvon, S; Davis, M; Houlden, H; Gibbons, V; Wood, N; (2012) Genetic linkage analysis of a large family with photoparoxysmal response. EPILEPSY RESEARCH , 99 (1-2) pp. 38-45. 10.1016/j.eplepsyres.2011.10.013.

Loane, C; Politis, M; Wu, K; O'Sullivan, SS; Woodhead, Z; Lawrence, AD; Lees, AJ; (2012) Drug-cue elicited frontal and limbic dysfunction in Parkinson's disease patients with dopamine dysregulation syndrome. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S245-S245). WILEY-BLACKWELL

Lohmann, E; Guerreiro, RJ; Erginel-Unaltuna, N; Gurunlian, N; Bilgic, B; Gurvit, H; Hanagasi, HA; ... Singleton, A; + view all (2012) Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. NEUROBIOLOGY OF AGING , 33 (8) 10.1016/j.neurobiolaging.2012.02.020.

Lubbe, SJ; Pittman, AM; Olver, B; Lloyd, A; Vijayakrishnan, J; Naranjo, S; Dobbins, S; ... Houlston, RS; + view all (2012) The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4. ONCOGENE , 31 (33) pp. 3777-3784. 10.1038/onc.2011.564.

Lubbe, SJ; Pittman, AM; Olver, B; Lloyd, A; Vijayakrishnan, J; Naranjo, S; Dobbins, S; ... Houlston, RS; + view all (2012) The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4. Oncogene , 31 (33) pp. 3777-3784. 10.1038/onc.2011.564.

Luk, C; Compta, Y; Magdalinou, N; Marti, MJ; Hondhamuni, G; Zetterberg, H; Blennow, K; ... de Silva, R; + view all (2012) Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. Journal of Neurochemistry 10.1111/j.1471-4159.2012.07911.x.

M

Maccecchini, ML; Chang, MY; Pan, C; John, V; Zetterberg, H; Greig, NH; (2012) Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-beta peptide and tau levels: target engagement, tolerability and pharmacokinetics in humans. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (9) pp. 894-902. 10.1136/jnnp-2012-302589.

Machado, P; Bernardo, A; Cravo, AR; Rodrigues, A; Malcata, A; Nour, D; Vieira-Sousa, E; ... Barcelos, A; + view all (2012) Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - December 2011 update. ACTA REUMATOLOGICA PORTUGUESA , 37 (1) pp. 40-47.

Machado, P; Bogas, M; Ribeiro, A; Costa, J; Neto, A; Sepriano, A; Raposo, A; ... Barcelos, A; + view all (2012) 2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis. ACTA REUMATOLOGICA PORTUGUESA , 37 (1) pp. 26-39.

Machado, P; Cortese, A; Morrow, J; Dewar, L; Hiscock, A; Miller, A; Brady, S; ... Hanna, MG; + view all (2012) The Natural History of Sporadic Inclusion Body Myositis-an Observational Longitudinal Study. In: (Proceedings) Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP). (pp. S99-S100). WILEY-BLACKWELL

Machado, P; Hudson, J; Miller, A; Morrow, J; Parton, M; Bushby, K; Hanna, M; (2012) VALOSIN CONTAINING PROTEIN (VCP) AND MYOFIBRILLAR MYOPATHIES (MFM) GENES' MUTATIONS ARE NOT ASSOCIATED WITH SPORADIC INCLUSION BODY MYOSITIS (sIBM). In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Machado, P; Hudson, J; Miller, A; Morrow, J; Parton, M; Bushby, K; Hanna, MG; (2012) Myofibrillar myopathies (MFM), valosin containing protein (VCP) and glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (GNE) genes' mutations are not associated with sporadic inclusion body myositis (sIBM). In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S30-S30). PERGAMON-ELSEVIER SCIENCE LTD

Machado, P; Landewe, RBM; Braun, J; Baraliakos, X; Hermann, K-GA; Hsu, B; Baker, D; (2012) MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. ANNALS OF THE RHEUMATIC DISEASES , 71 (12) pp. 2002-2005. 10.1136/annrheumdis-2012-201999.

Machado, P; Santos, MJ; Fonseca, JE; (2012) Recommendations of the Portuguese Society of Rheumatology: A contribution to quality clinical practice. Acta Reumatologica Portuguesa , 37 (1) pp. 7-8.

Machado, P; Santos, MJ; Fonseca, JE; (2012) Recommendations of the Portuguese Society of Rheumatology: a contribution towards improving the quality of health care. ACTA REUMATOLOGICA PORTUGUESA , 37 (1) pp. 7-8.

Magdalinou, NK; Ling, H; Schott, JM; Lees, AJ; (2012) Normal pressure hydorcephalus or progressive supranuclear palsy? A clinicopathological case series. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S295-S295). WILEY-BLACKWELL

Magdalinou, NK; Luk, C; Compta, Y; Marti, MJ; Lees, AJ; de Silva, R; (2012) Novel method for quantification of 3R-and 4R-tau isoforms in the cerebrospinal fluid of patients with atypical parkinsonian syndromes. In: (pp. S385-S386).

Mahoney, C; Beck, J; Rohrer, J; Lashley, T; Mok, K; Yeatman, T; Shakespeare, T; ... Warren, J; + view all (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. In: (Proceedings) 8th International Conference on Frontotemporal Dementias. (pp. pp. 86-87). KARGER

Mahoney, CJ; Beck, J; Rohrer, JD; Lashley, T; Mok, K; Shakespeare, T; Yeatman, T; ... Warren, JD; + view all (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain , 135 (3) 736 - 750. 10.1093/brain/awr361. Green open access
file

Majounie, E; Abramzon, Y; Renton, AE; Perry, R; Bassett, SS; Pletnikova, O; Troncoso, JC; ... Traynor, BJ; + view all (2012) Repeat Expansion in C9ORF72 in Alzheimer's Disease. NEW ENGLAND JOURNAL OF MEDICINE , 366 (3) pp. 283-284. 10.1056/NEJMc1113592.

Majounie, E; Renton, AE; Mok, K; Dopper, EG; Waite, A; Rollinson, S; Chiò, A; ... Traynor, BJ; + view all (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurology , 11 (4) 323 - 330. 10.1016/S1474-4422(12)70043-1. Green open access
file

Mandemakers, W; Snellinx, A; O'Neill, MJ; de Strooper, B; (2012) LRRK2 expression is enriched in the striosomal compartment of mouse striatum. NEUROBIOLOGY OF DISEASE , 48 (3) pp. 582-593. 10.1016/j.nbd.2012.07.017.

Manzoni, C; Dihanich, S; Mamais, A; Cai, H; Bandopadhyay, R; Lewis, PA; (2012) LRRK2 and autophagy: Molecular targets for Parkinson's disease? In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S489-S489). WILEY-BLACKWELL

Martins, S; Soong, B-W; Wong, VCN; Giunti, P; Stevanin, G; Ranum, LPW; Sasaki, H; ... Nicholson, GA; + view all (2012) Mutational Origin of Machado-Joseph Disease in the Australian Aboriginal Communities of Groote Eylandt and Yirrkala. ARCHIVES OF NEUROLOGY , 69 (6) pp. 746-751. 10.1001/archneurol.2011.2504.

Massey, LA; Micallef, C; Paviour, DC; O'Sullivan, SS; Ling, H; Williams, DR; Kallis, C; ... Jäger, HR; + view all (2012) Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Movement Disorders , 27 (14) 1754 - 1762. 10.1002/mds.24968.

Massey, LA; Miranda, MA; Zrinzo, L; Al-Helli, O; Parkes, HG; Thornton, JS; So, P-W; ... Yousry, TA; + view all (2012) High resolution MR anatomy of the subthalamic nucleus: Imaging at 9.4 T with histological validation. NEUROIMAGE , 59 (3) pp. 2035-2044. 10.1016/j.neuroimage.2011.10.016.

Massey, LA; Miranda, MA; Zrinzo, L; Al-Helli, O; Parkes, HG; Thornton, JS; So, P-W; ... Yousry, TA; + view all (2012) High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. Neuroimage , 59 (3) pp. 2035-2044. 10.1016/j.neuroimage.2011.10.016.

Matilde, L; Eichler, F; Hornemann, T; Murphy, SM; Polke, J; Bull, K; Houlden, H; (2012) HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 1: CORRELATION OF SEVERITY AND PLASMA ATYPICAL DEOXY-SPHYNGOID BASES. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Matsuki, T; Zaka, M; Guerreiro, R; van der Brug, MP; Cooper, JA; Cookson, MR; Hardy, JA; (2012) Identification of Stk25 as a genetic modifier of Tau phosphorylation in Dab1-mutant mice. PLoS One , 7 (2) , Article e31152. 10.1371/journal.pone.0031152. Green open access
file

Matta, S; Van Kolen, K; da Cunha, R; van den Bogaart, G; Mandemakers, W; Miskiewicz, K; De Bock, P-J; ... Verstreken, P; + view all (2012) LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis. NEURON , 75 (6) pp. 1008-1021. 10.1016/j.neuron.2012.08.022.

Matthews, E; Plotz, PH; Portaro, S; Parton, M; Elliott, P; Humbel, RL; Holton, JL; ... Hanna, MG; + view all (2012) A case of necrotizing myopathy with proximal weakness and cardiomyopathy. NEUROLOGY , 78 (19) pp. 1527-1532.

Mattsson, N; Andreasson, U; Carrillo, MC; Persson, S; Shaw, LM; Zegers, I; Zetterberg, H; (2012) Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers. BIOMARKERS IN MEDICINE , 6 (4) pp. 401-407. 10.2217/BMM.12.41.

Mattsson, N; Olsson, M; Gustavsson, MK; Kosicek, M; Malnar, M; Mansson, J-E; Blomqvist, M; ... Portelius, E; + view all (2012) Amyloid-beta metabolism in Niemann-Pick C disease models and patients. METABOLIC BRAIN DISEASE , 27 (4) pp. 573-585. 10.1007/s11011-012-9332-8.

Mattsson, N; Portelius, E; Rolstad, S; Gustavsson, M; Andreasson, U; Stridsberg, M; Wallin, A; ... Zetterberg, H; + view all (2012) Longitudinal Cerebrospinal Fluid Biomarkers over Four Years in Mild Cognitive Impairment. JOURNAL OF ALZHEIMERS DISEASE , 30 (4) pp. 767-778. 10.3233/JAD-2012-120019.

Mattsson, N; Rajendran, L; Zetterberg, H; Gustavsson, M; Andreasson, U; Olsson, M; Brinkmalm, G; ... Portelius, E; + view all (2012) BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system. PLoS One , 7 (2) , Article e31084. 10.1371/journal.pone.0031084. Green open access
file

Mattsson, N; Rosen, E; Hansson, O; Andreasen, N; Parnetti, L; Jonsson, M; Herukka, S-K; ... Zetterberg, H; + view all (2012) Age and diagnostic performance of Alzheimer disease CSF biomarkers. NEUROLOGY , 78 (7) pp. 468-476. 10.1212/WNL.0b013e3182477eed.

Mattsson, N; Zegers, I; Andreasson, U; Bjerke, M; Blankenstein, MA; Bowser, R; Carrillo, MC; ... Portelius, E; + view all (2012) Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid beta 42. BIOMARKERS IN MEDICINE , 6 (4) pp. 409-417. 10.2217/BMM.12.39.

Mattsson, N; Zetterberg, H; (2012) What is a certified reference material? BIOMARKERS IN MEDICINE , 6 (4) pp. 369-370. 10.2217/BMM.12.37.

Mattsson, N; Zetterberg, H; Bianconi, S; Yanjanin, NM; Fu, R; Månsson, J-E; Porter, FD; (2012) Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C. JIMD Rep , 3 pp. 45-52. 10.1007/8904_2011_47.

McGlincy, NJ; Valomon, A; Chesham, JE; Maywood, ES; Hastings, MH; Ule, J; (2012) Regulation of alternative splicing by the circadian clock and food related cues. GENOME BIOLOGY , 13 (6) 10.1186/gb-2012-13-6-r54.

McNaughton, D; Knight, W; Guerreiro, R; Ryan, N; Lowe, J; Poulter, M; Nicholl, DJ; ... Mead, S; + view all (2012) Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobioly of Aging , 33 (2) 426.e13 - 426.e21. 10.1016/j.neurobiolaging.2010.10.010. Green open access
file

McNeill, A; Duran, R; Proukakis, C; Bras, J; Hughes, D; Mehta, A; Hardy, J; ... Schapira, AHV; + view all (2012) Hyposmia and cognitive impairment in Gaucher disease patients and carriers. MOVEMENT DISORDERS , 27 (4) pp. 526-532. 10.1002/mds.24945.

Mead, S; Beck, J; Poulter, M; Rohrer, J; Adamson, G; Hensman, D; Polke, J; ... Collinge, J; + view all (2012) Large C9ORF72 hexanucleotide expansions arise spontaneously in the healthy population but can be distinguished from pathogenic mutations by Sothern Blotting. In: (Proceedings) 8th International Conference on Frontotemporal Dementias. (pp. pp. 285-286). KARGER

Mencacci, NE; Labrum, R; Haworth, A; Sweeney, M; Pittman, A; Stamelou, M; Fletcher, NA; ... Hardy, J; + view all (2012) Is anything lying behind parkin heterozygous mutations? In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S462-S463). WILEY-BLACKWELL

Michaki, V; Guix, FX; Vennekens, K; Munck, S; Dingwall, C; Davis, JB; Townsend, DM; ... Wahle, T; + view all (2012) Down-regulation of the ATP-binding Cassette Transporter 2 (Abca2) Reduces Amyloid-beta Production by Altering Nicastrin Maturation and Intracellular Localization. JOURNAL OF BIOLOGICAL CHEMISTRY , 287 (2) pp. 1100-1111. 10.1074/jbc.M111.288258.

Miller, A; Ahmed, M; Hanna, MG; Greensmith, L; (2012) DEVELOPING NEW THERAPEUTIC STRATEGIES FOR INCLUSION BODY MYOSITIS. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Mittag, F; Buechel, F; Saad, M; Jahn, A; Schulte, C; Bochdanovits, Z; Simon-Sanchez, J; ... Sharma, M; + view all (2012) Use of support vector machines for disease risk prediction in genome-wide association studies: Concerns and opportunities. HUMAN MUTATION , 33 (12) pp. 1708-1718. 10.1002/humu.22161.

Mittag, F; Büchel, F; Saad, M; Jahn, A; Schulte, C; Bochdanovits, Z; Simón-Sánchez, J; ... Sharma, M; + view all (2012) Use of support vector machines for disease risk prediction in genome-wide association studies: Concerns and opportunities. Human Mutation , 33 (12) pp. 1708-1718. 10.1002/humu.22161.

Mok, K; Traynor, BJ; Schymick, J; Tienari, PJ; Laaksovirta, H; Peuralinna, T; Myllykangas, L; ... Hardy, J; + view all (2012) Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiology of Disease , 33 (1) 209.e3 - 209.e8. 10.1016/j.neurobiolaging.2011.08.005. Green open access
file

Mok, KY; Koutsis, G; Schottlaender, LV; Polke, J; Panas, M; Houlden, H; (2012) High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. In: ELSEVIER SCIENCE INC

Mok, KY; Koutsis, G; Schottlaender, LV; Polke, J; Panas, M; Houlden, H; (2012) High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. Neurobioly of Aging , 33 (8) 1851.e1 - 1851.e5. 10.1016/j.neurobiolaging.2012.02.021. Green open access
file

Mok, KY; Sailer, A; Schottlaender, L; (2012) Homozygosity and copy number variant analysis in multiple system atrophy. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S463-S463). WILEY-BLACKWELL

Morales-Briceno, H; Rodriguez-Violante, M; Cervantes-Arriaga, A; Irani, SR; Lees, AJ; Silveira-Moriyama, L; (2012) Opsoclonus Myoclonus Syndrome associated with GQ1b Antibodies. MOVEMENT DISORDERS , 27 (13) pp. 1615-1616. 10.1002/mds.25169.

Morrow, J; Sinclair, CDJ; Fischmann, A; Thornton, JS; Yousry, TA; Reilly, MM; Hanna, MG; (2012) MRI QUANTIFICATION OF LOWER LIMB MUSCLE FATTY ATROPHY: A POTENTIAL OUTCOME MEASURE IN CHRONIC NEUROMUSCULAR DISEASES. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Morrow, JM; Sinclair, CDJ; Fischmann, A; Thornton, JS; Reilly, MM; Hanna, MG; Yousry, TA; (2012) MRI quantification of abnormal muscle water distribution in chronic neuromuscular diseases: a sensitive biomarker. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S33-S33). PERGAMON-ELSEVIER SCIENCE LTD

Moscovich, M; Munhoz, R; Teive, H; Raskin, S; Liu, J; McFarland, K; Ashizawa, T; ... Silveira-Moriyama, L; + view all (2012) To Investigate Olfactory Impairment in Cerebellar Ataxia. In: (Proceedings) 64th Annual Meeting of the American-Academy-of-Neurology (AAN). LIPPINCOTT WILLIAMS & WILKINS

Moscovich, M; Munhoz, RP; Teive, HA; Raskin, S; Carvalho, MDJ; Barbosa, ER; Ranvaud, R; ... Silveira-Moriyama, L; + view all (2012) Olfactory impairment in familial ataxias. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (10) pp. 970-974. 10.1136/jnnp-2012-302770.

Moscovich, M; Munhoz, RP; Teive, HA; Raskin, S; De Carvalho, MJ; Barbosa, ER; Ranvaud, R; ... Silveira-Moriyama, L; + view all (2012) Olfactory impairment in familial ataxias. Journal of Neurology, Neurosurgery and Psychiatry , 83 (10) pp. 970-974. 10.1136/jnnp-2012-302770.

Moverare-Skrtic, S; Johansson, P; Mattsson, N; Hansson, O; Wallin, A; Johansson, J-O; Zetterberg, H; ... Svensson, J; + view all (2012) Leukocyte Telomere Length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's Disease: A pilot study. EXPERIMENTAL GERONTOLOGY , 47 (2) pp. 179-182. 10.1016/j.exger.2011.12.005.

Murphy, S; Pandraud, A; Liu, Y; Fawcett, K; Polke, JM; Davidson, G; Laura, M; ... Reilly, MM; + view all (2012) CHARCOT-MARIE-TOOTH DISEASE: GENETIC DIAGNOSES IN A SPECIALIST CLINIC. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. B M J PUBLISHING GROUP

Murphy, SM; Davidson, GL; Brandner, S; Houlden, H; Reilly, MM; (2012) Mutation in FAM134B causing severe hereditary sensory neuropathy. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (1) pp. 119-120. 10.1136/jnnp.2010.228965.

Murphy, SM; Davidson, GL; Brandner, S; Houlden, H; Reilly, MM; (2012) Mutation in FAM134B causing severe hereditary sensory neuropathy. Journal of Neurology, Neurosurgery and Psychiatry , 83 (1) pp. 119-120. 10.1136/jnnp.2010.228965.

Murphy, SM; Davidson, GL; Brandner, S; Houlden, H; Reilly, MM; (2012) Mutation in FAM134B causing severe hereditary sensory neuropathy. J Neurol Neurosurg Psychiatry , 83 (1) pp. 119-120. 10.1136/jnnp.2010.228965.

Murphy, SM; Khan, U; Alifrangis, C; Hazell, S; Hrouda, D; Blake, J; Ball, J; ... Reilly, MM; + view all (2012) Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (2) pp. 232-233. 10.1136/jnnp.2010.223271.

Murphy, SM; Laura, M; Ernst, D; Liu, Y-T; Blake, J; Donaghy, M; Winer, J; ... Reilly, MM; + view all (2012) Clinical and genetic characterisation of hereditary sensory neuropathy type 1 caused by mutations in SPTLC2. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S19-S19). PERGAMON-ELSEVIER SCIENCE LTD

Murphy, SM; Laura, M; Fawcett, K; Pandraud, A; Liu, Y-T; Davidson, GL; Rossor, AM; ... Reilly, MM; + view all (2012) Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 83 (7) pp. 706-710. 10.1136/jnnp-2012-302451.

Murphy, SM; Laura, M; Fawcett, K; Pandraud, A; Liu, YT; Davidson, GL; Rossor, AM; ... Reilly, MM; + view all (2012) Charcot-Marie-Tooth disease: Frequency of genetic subtypes and guidelines for genetic testing. Journal of Neurology, Neurosurgery and Psychiatry , 83 (7) pp. 706-710. 10.1136/jnnp-2012-302451.

Murphy, SM; Ovens, R; Polke, J; Siskind, CE; Laurà, M; Bull, K; Ramdharry, G; ... Reilly, MM; + view all (2012) X inactivation in females with X-linked Charcot-Marie-Tooth disease. Neuromuscular Disorders , 22 (7) 617 - 621. 10.1016/j.nmd.2012.02.009. Green open access
file

N

Nesbitt, V; Pitceathly, R; Cockell, S; Poulton, J; Rahman, S; Hanna, M; Turnbull, D; (2012) The medical research council neuromuscular centre for translational research mitochondrial disease patient cohort study UK: from conceptualisation to utilisation. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S24-S24). PERGAMON-ELSEVIER SCIENCE LTD

Neselius, S; Brisby, H; Theodorsson, A; Blennow, K; Zetterberg, H; Marcusson, J; (2012) CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma. PLoS One , 7 (4) , Article e33606. 10.1371/journal.pone.0033606. Green open access
file

Nesic, I; Guix, FX; Vennekens, K; Michaki, V; Van Veldhoven, PP; Feiguin, F; De Strooper, B; ... Wahle, T; + view all (2012) Alterations in phosphatidylethanolamine levels affect the generation of A ss. AGING CELL , 11 (1) pp. 63-72. 10.1111/j.1474-9726.2011.00760.x.

Nethisinghe, S; Menon, RP; Faggiano, S; Vannocci, T; Rezaei, H; Pemble, S; Sweeney, MG; ... Giunti, P; + view all (2012) The role of interruptions in the polyglutamine tract of ATXN1 in SCA1 pathology. In: (Proceedings) British Human Genetics Conference. (pp. S91-S91). BMJ PUBLISHING GROUP

Nikitopoulou, I; Oikonomou, N; Karouzakis, E; Sevastou, I; Nikolaidou-Katsaridou, N; Zhao, Z; Mersinias, V; ... Aidinis, V; + view all (2012) Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis. JOURNAL OF EXPERIMENTAL MEDICINE , 209 (5) pp. 923-931. 10.1084/jem.20112012.

Noyce, A; Bestwick, J; Hawkes, CH; Knowles, CH; Hardy, J; Lees, AJ; Silveira-Moriyama, L; ... Schrag, A; + view all (2012) AN ALGORITHM TO IDENTIFY INDIVIDUALS AT HIGH-RISK OF PARKINSON'S DISEASE IN THE COMMUNITY. In:

Noyce, A; Silveira-Moriyama, L; Lees, AJ; Schrag, A; Bestwick, J; Hawkes, CH; Giovannoni, G; ... Knowles, CH; + view all (2012) A PILOT STUDY OF AN ALGORITHM DESIGNED TO IDENTIFY PARKINSON'S DISEASE IN THE EARLY, NON-MOTOR PHASE. In:

Noyce, A; Treacy, C; Budu, C; Fearnley, J; Lees, AJ; Giovannoni, G; (2012) THE NEW BRADYKINESIA AKINESIA INCOORDINATION (BRAIN) TEST: AN ONLINE TEST OF UPPER LIMB MOVEMENT. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. BMJ PUBLISHING GROUP

Noyce, AJ; Bestwick, J; Silveira-Moriyama, L; Hawkes, CH; Giovannoni, G; Lees, AJ; Schrag, A; (2012) Risk factors and early non-motor features for Parkinson's disease: A systematic review and meta-analysis. In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S4-S4). WILEY-BLACKWELL

Noyce, AJ; Bestwick, JP; Silveira-Moriyama, L; Hawkes, CH; Giovannoni, G; Lees, AJ; Schrag, A; (2012) Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease. ANNALS OF NEUROLOGY , 72 (6) pp. 893-901. 10.1002/ana.23687.

Noyce, AJ; Bestwick, JP; Silveira-Moriyama, L; Hawkes, CH; Giovannoni, G; Lees, AJ; Schrag, A; (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Annals of Neurology , 72 (6) pp. 893-901. 10.1002/ana.23687.

Noyce, AJ; Silveira-Moriyama, L; Gilpin, P; Ling, H; Howard, R; Lees, AJ; (2012) Severe dysphagia as a presentation of Parkinson's disease. MOVEMENT DISORDERS , 27 (3) pp. 457-458. 10.1002/mds.24006.

Noyce, AJ; Treacy, C; Budu, C; Fearnley, J; Lees, AJ; Giovannoni, G; (2012) The New Bradykinesia Akinesia Incoordination (BRAIN) Test: Preliminary Data from an Online Test of Upper Limb Movement. MOVEMENT DISORDERS , 27 (1) pp. 157-158. 10.1002/mds.23947.

O

O'Flanagan, CH; Morais, V; Kloos, K; Wurst, W; de Strooper, B; O'Neill, C; (2012) Investigating the role of PTEN-induced kinase 1 in cancer development and pathogenesis. In: AMER ASSOC CANCER RESEARCH

O'Sullivan, SS; Cheshire, P; Djamshidian, A; Bertram, K; Williams, DR; Lees, AJ; Foltynie, T; (2012) Is the brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism associated with impulsive-compulsive behaviours in Parkinson's disease? In: (Proceedings) 16th International Congress of Parkinson's Disease and Movement Disorders. (pp. S464-S465). WILEY-BLACKWELL

Olsson, B; Malmestrom, C; Basun, H; Annas, P; Hoglund, K; Lannfelt, L; Andreasen, N; ... Blennow, K; + view all (2012) Extreme Stability of Chitotriosidase in Cerebrospinal Fluid makes it a Suitable Marker for Microglial Activation in Clinical Trials. JOURNAL OF ALZHEIMERS DISEASE , 32 (2) pp. 273-276. 10.3233/JAD-2012-120931.

Ozawa, T; Revesz, T; Paviour, D; Lees, AJ; Quinn, N; Tada, M; Kakita, A; ... Holton, JL; + view all (2012) Difference in MSA Phenotype Distribution Between Populations: Genetics or Environment? JOURNAL OF PARKINSONS DISEASE , 2 (1) pp. 7-18. 10.3233/JPD-2012-11056.

P

Paisan-Ruiz, C; Li, A; Schneider, SA; Holton, JL; Johnson, R; Kidd, D; Chataway, J; ... Houlden, H; + view all (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. NEUROBIOLOGY OF AGING , 3